Form D · Venture Capital Fund
Health Catalyst Capital Continuation Fund I, L.P.
New York, NY · CIK 0002032050
Offering snapshot reported Aug 5, 2024 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 5, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-520620
A placement agent has been retained and will be apportioned a fee as specified in the placement agent agreement with the Issuer.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| UBS Securities LLC | 7654 |
Source: Form D, filed Aug 5, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
HEALTH CATALYST CAPITAL CONTINUATION FUND I, L.P.
Investment adviser: HEALTH CATALYST CAPITAL MANAGEMENT, LLC
- Gross asset value
- $17.1M
- Beneficial owners
- 2
- ADV minimum commitment
- $0
Reported in Form ADV on Apr 28, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO USA, LLP
PCAOB 243
Filing source
Form ADV 2099228 · Apr 28, 2026 · Schedule D 7.B.(1), fund 805-2545062603
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Boorady | Executive |
| N/A Health Catalyst Capital Continuation Fund Gp I, Llc | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022